Autotransfusion Devices Market Size
Medical Equipment

Autotransfusion Devices Market Forecast 2023-2027 By The Business Research Company

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s autotransfusion devices market report forecasts the autotransfusion devices market size to grow to $1.47 Billion by 2027, with a CAGR (compound annual growth rate) of more than 5%.

Learn More On The Autotransfusion Devices Market Report 2023 – https://www.thebusinessresearchcompany.com/report/autotransfusion-devices-global-market-report

Autotransfusion Devices Market Size Forecast
The global autotransfusion devices market is expected to grow from $1.11 billion in 2022 to $1.17 billion in 2023 at a compound annual growth rate (CAGR) of 5.65%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global autotransfusion devices market size is expected to reach $1.47 billion in 2027 at a CAGR of 5.81%.

North America held the largest autotransfusion devices market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Autotransfusion Devices Market Driver ­– Increase In Number Of Surgical Procedures
For example, according to a report published in November 2021 by the American Academy of Orthopaedic Surgeons (AAOS), a non-profit orthopaedic organisation based in the United States, and the Agency for Healthcare Research and Quality (AHRQ), a healthcare research agency based in the United States, 700,000 knee replacement surgeries and approximately 450,000 hip replacement surgeries are performed annually in the United States. Furthermore, according to a 2021 release by the University of Alabama, the flagship university of a US-based state, 320,000 Coronary Artery Bypass Grafting surgeries were performed in the US in 2020. As a result, the rising number of surgical procedures is predicted to boost the autotransfusion devices market forward.

Request for A Sample Of The Global Autotransfusion Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10275&type=smp

Key Autotransfusion Devices Market Trend – Product Innovation
Major autotransfusion device firms are focusing on producing unique solutions to strengthen their position and obtain a competitive edge. For example, ProCell Surgical Inc., a medical equipment manufacturer based in the United States, will launch the ProCell in June 2020. It is the first medical device to automate the time-consuming and labor-intensive procedure of surgical sponge-blood retrieval for intraoperative autotransfusion (IAT). It is specially intended to improve the hospital’s surgical blood conservation efforts by applying a prolonged compressive force and extracting blood from surgical sponges using an operating room’s regular vacuum suction.

Autotransfusion Devices Market Segment
1) By Product Type: Autotransfusion Systems, Consumables And Accessories
2) By Application: Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics And Gynecology Surgeries, Other Applications
3) By End-Use: Hospitals, Specialty Clinics, Other End Users

Autotransfusion Devices Market Major Players and Strategies
Major players in the autotransfusion devices market are Becton Dickinson and Company, Medtronic PLC, LivaNova PLC, Haemonetics Corporation, Fresenius SE & Co KGaA, TERUMO BCT, Asahi Kasei Medical Co Ltd., Miltenyi Biotec, B. Braun Melsungen AG, GE Healthcare, Cerus Corporation, Fresenius Kabi AG, Stryker Corporation, Atrium Medical Technologies, Brightwake Ltd and Getinge AB.

Morgan Stanley Infrastructure Inc., a significant investment management and infrastructure firm based in the United States, acquired Specialty Care Inc. for an undisclosed sum in October 2021. Morgan Stanley Infrastructure’s first investment in healthcare intended to improve patient care results and the company’s growth. Specialty Care Inc. is a provider of autotransfusion system services situated in the United States.

The Autotransfusion Devices Global Market Report 2023 covers regional data on autotransfusion devices market size, autotransfusion devices market trends and drivers, opportunities, strategies, and autotransfusion devices market competitor analysis. The countries covered in the autotransfusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Instead of using donated blood, autotransfusion devices collect and reinfuse a patient’s blood during a medical operation. This procedure, also known as autologous blood transfusion, can help decrease the need for allogenic (separate-donor) blood transfusions. Autotransfusion devices are frequently utilised in trauma patients in the ER and during surgeries.

View More Reports Related To The Autotransfusion Devices Market –
ENT Devices Global Market Report 2023
Orthopedic Devices Global Market Report 2023
Cardiovascular Devices Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas
+1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: